FDA Approves Expanded Uses for GARDASIL in Preventing Cancer

Video Details

• Category: Pop Culture
• Tags: administration, application, biologics, cancer, cervical, co, drug, dysplastic, fda, food, gardasil, genital, hpv, lesions, license, merck, precancerous, priority, review, sbla, supplemental, us, vaginal, vulvar, warts
• 260 Views

Uploaded Sep. 17, 2008 by
newsinfusion

September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26. These two HPV types cause 70 percent of cervical cancers, and are known to also cause some vulvar and vaginal cancers, but the percentages are not well defined.